Local Manufacturing, Strategic Partnerships, and National Initiatives Drive the UAE’s Pharmaceutical Ambitions
The pharmaceutical market in the UAE is poised for substantial growth, supported by a combination of government commitment, an expanding population, and rising healthcare needs. With a clear vision for industrial development, the UAE is positioning itself as a regional leader in the pharmaceutical sector. Key players like Globalpharma, a subsidiary of Dubai Investments, are playing a crucial role in this transformation by contributing to national initiatives, advancing local manufacturing, and strengthening the country’s self-reliance in pharmaceuticals.
Globalpharma’s Role in National Growth Initiatives
Globalpharma is actively driving efforts that align with two key national initiatives: Operation 300bn and the “Make it in the Emirates” vision. As Basem Al Barahmeh, General Manager of Globalpharma, shared in a recent interview, the company is at the forefront of localization efforts, expanding its operations and reinforcing the UAE’s domestic supply chain. Globalpharma’s contributions extend beyond the local market, with its global export activities playing a key role in enhancing the UAE’s economic footprint.
Al Barahmeh highlighted the company’s impressive 16% year-on-year growth in UAE sales, reaching $49 million, underscoring its contribution to the nation’s economic resilience. “Through strategic partnerships, we are fostering a robust industrial ecosystem and driving growth through innovation in the pharmaceutical sector,” Al Barahmeh said. This commitment to expanding local manufacturing capabilities ensures the company delivers a diverse range of high-quality medications to meet the UAE’s growing healthcare demands.
Investing in Research, Innovation, and Talent Development
A core part of Globalpharma’s mission is to strengthen the UAE’s pharmaceutical sector through investment in research and development, as well as talent cultivation. By integrating cutting-edge research and new technologies, Globalpharma is creating innovative therapies that will position the UAE as a leader in pharmaceutical excellence.
The company’s strategic partnership with global pharmaceutical giants such as GSK reflects its dedication to developing advanced medicines. Local production of anti-infective medications, along with the introduction of herbal medicines, is helping to diversify the UAE’s pharmaceutical offerings while ensuring the country’s self-sufficiency in essential healthcare products.
Additionally, Globalpharma is committed to developing local talent by offering training and development programs designed to equip the UAE workforce with the skills needed to drive industry innovation.
Aiming for Self-Sufficiency and Global Competitiveness
The trend of local manufacturing has become more pronounced, with companies like Globalpharma setting a strong example. The UAE’s emphasis on reducing reliance on imports has contributed to a more self-sufficient pharmaceutical industry. By lowering logistics costs through local production, Globalpharma can offer high-quality medicines at more affordable prices.
The company’s efforts to expand its export markets further solidify the UAE’s competitive edge in the global pharmaceutical industry. “Our focus on building international collaborations with leading pharmaceutical companies, combined with our strong local presence, ensures that we continue to lead the charge in the region,” said Al Barahmeh.
The Path Forward
Looking ahead, Globalpharma remains committed to supporting the UAE’s vision of becoming a regional pharmaceutical hub. By attracting foreign investment, fostering innovation through joint research initiatives, and increasing local manufacturing capabilities, the company aims to drive the next phase of growth for the UAE’s pharmaceutical sector.
Through these efforts, Globalpharma is helping to shape a future where the UAE not only meets its own healthcare needs but also emerges as a global player in the pharmaceutical market.
